Clinical OMICS

MAR-APR 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 30 of 51

Learn more at // Questions? Email // Access the data at GENIE aggregates existing and ongoing clinical genotyping efforts from the project participants into a single registry and links this data to select clinical outcomes, providing a real-world dataset that can answer questions about the development and treatment of cancer, including rare cancers and rare variants of common cancers. Access the data at AACR Project GENIE is an international, pancancer registry, built through data sharing, with the goals of powering precision oncology and clinical decision making, and is driven by openness, transparency, and inclusion. • Dana-Farber Cancer Institute • Institut Gustave Roussy, France • Memorial Sloan Kettering Cancer Center • The Netherlands Cancer Institute on behalf of the Center for Personalized Cancer Treatment, The Netherlands • Children's Hospital of Philadelphia • Cancer Research UK Cambridge Centre • Duke Cancer Institute, Duke University • Herbert Irving Comprehensive Cancer Center, Columbia University • Swedish Cancer Institute • Providence Cancer Institute • Princess Margaret Cancer Centre, Canada • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland • University of Texas MD Anderson Cancer Center • Vanderbilt-Ingram Cancer Center • Wake Forest University Health Sciences • The University of Chicago • UCSF Helen Diller Family Comprehensive Cancer Center • Vall d' Hebron Institute of Oncology, Spain • Yale Cancer Center, Yale University AACR Project GENIE® Participants

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2019